Navigation Links
Cambrex Reports Fourth Quarter and Full Year 2008 Results
Date:2/11/2009

ence call. A telephone replay of the conference call will be available through Thursday, February 19, 2009 by calling 1-800-642-1687 for domestic and +1-706-645-9291 for international. Please use the pass code 84377791 to access the replay.

Forward Looking Statements

This news release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and Rule 3b-6 under the Securities Exchange Act of 1934, as amended, including, without limitation, statements regarding expected performance, especially expectations with respect to sales, research and development expenditures, earnings per share, capital expenditures, acquisitions, divestitures, collaborations, or other expansion opportunities. These statements may be identified by the fact that words such as "expects", "anticipates", "intends", "estimates", "believes" or similar expressions are used in connection with any discussion of future financial or operating performance. Any forward-looking statements are qualified in their entirety by reference to the risk factors discussed in the Company's periodic reports filed with the U.S. Securities and Exchange Commission. Any forward-looking statements contained herein are based on current plans and expectations and involve risks and uncertainties that could cause actual outcomes and results to differ materially from current expectations including, but not limited to, global economic trends, pharmaceutical outsourcing trends, competitive pricing or product developments, government legislation or regulations (particularly environmental issues), tax rate, interest rate, technology, manufacturing and legal issues, including the outcome of outstanding litigation disclosed in the Company's public filings, changes in foreign exchange rates, uncollectible receivables, loss on disposition of assets, cancellation or delays in renewal of contracts, lack of suitable raw materia
'/>"/>

SOURCE Cambrex Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Cambrex To Announce Third Quarter 2007 Financial Results on November 1, 2007
2. Cambrex Signs Agreement To Acquire ProSyntest AS
3. Cambrex Reports Fourth Quarter and Full-Year 2007 Results
4. Cambrex Customer Announced Recall
5. Cambrex to Announce First Quarter 2008 Financial Results on May 1, 2008
6. Cambrex Presentation at The JPMorgan Healthcare Conference to be Webcast
7. Skinvisible and Cambrex Enter Into Agreement to Develop Acne Products
8. Cambrex to Announce Fourth Quarter 2008 Financial Results on February 11, 2009
9. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
10. Haemacure Reports Third Quarter 2007 Results
11. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... (PRWEB) May 06, 2015 The Beryl ... 1 of Patient Experience Journal (PXJ), an international, ... practices around understanding and improving patient experience. The second ... patient experience conversation globally, helps align the voices engaged ... , Published in association with The Beryl Institute, ...
(Date:5/6/2015)... “ SideChef ” was featured on NewsWatch as ... latest and coolest applications on the market for iOS, Android, and ... the app review and shared with viewers how this application walks ... to be a good navigator people had to know how to ... is a master navigator. Well what if people could “GPS” their ...
(Date:5/6/2015)... Inversion Studios, a full-service training ... Pilates classes, provides personalized individual instruction and now ... its new Pilates Ring magic circle. , Inversion ... stronger, more centered and graceful, Inversion Studios and ... to healthy fitness through yoga and Pilates. With ...
(Date:5/6/2015)... 06, 2015 Vancouver Chiropractic Clinic, ... their new blog containing the Canadian Physical Activity ... Canadian Society for Exercise Physiology (CSEP). Since the ... health and fitness research and personal training in ... are highly beneficial and a rich resource for ...
(Date:5/6/2015)... Anitoa Systems, (“Anitoa”), a Palo Alto startup established ... successfully demonstrated a handheld real time quantitative-polymerase-chain-reaction system (qPCR) ... qPCR is shown to be capable of detecting several ... C, and E. Coli. This qPCR system has achieved ... 9 orders of magnitude dynamic range. A key ...
Breaking Medicine News(10 mins):Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 3Health News:Vancouver Chiropractor Shares Canadian Physical Activity and Sedentary Behavior Guidelines by CSEP in New Blog 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 3
... all been there: sitting,in the doctor,s waiting room for ... when a long wait is coupled with a hurried ... , "When doctors keep their ... combination of factors can be toxic," says patient satisfaction,expert ...
... Dictation technology within the NHS produces significant efficiency gains. , ... ... today announced that Sheffield Teaching Hospitals NHS Foundation Trust has implemented ... 5 hospitals on 2 campuses in one of the largest rollouts ...
... in an asthmatic,s exhaled breath can portend worsening ... attack linked to underlying airway inflammation. This has ... children, of significant interest as a potential way ... outcomes. However, a recent multi-center prospective study found ...
... has ignored their cost saving suggestionsHARRISBURG, Pa., Jan. 6 ... on closing the state,s budget shortfall, SEIU Local 668, ... across Pennsylvania, said they have identified millions of dollars ... should cancel contracts with private contractors for work that ...
... National Cholesterol Education Program tools, NCEP, do not accurately ... at the Yale University School of Medicine in New ... who had no history of coronary heart disease; although ... Lipitor) because of increased risk of developing coronary heart ...
... 6 Gen-Probe Incorporated (Nasdaq: GPRO ) announced ... J.P. Morgan Healthcare Conference on Wednesday, January 14, 2009 at ... is scheduled to be webcast live and may be accessed ... at www.gen-probe.com . The webcast will be available for ...
Cached Medicine News:Health News:DrScore.com Identifies 'Toxic Combination' 2Health News:Sheffield Teaching Hospitals NHS Foundation Trust delivers same day patient discharge via BigHand Digital Dictation 2Health News:Sheffield Teaching Hospitals NHS Foundation Trust delivers same day patient discharge via BigHand Digital Dictation 3Health News:NO help: Nitric oxide monitoring does not help most children with asthma 2Health News:NO help: Nitric oxide monitoring does not help most children with asthma 3Health News:State Human Services Union Identifies Ways to Save Millions of Tax Dollars 2Health News:Gen-Probe to Webcast Presentation at the 27th Annual J.P. Morgan Healthcare Conference 2
(Date:5/6/2015)... 6, 2015  The fairness of the proposed acquisition ... Alexion Pharmaceuticals, Inc. ("Alexion") is being investigated by WeissLaw ... for possible breaches of fiduciary duty and other violations ... for agreeing to sell the Company to Alexion.  On ... for Alexion to acquire GEVA in a transaction valued ...
(Date:5/6/2015)... -- Cardica, Inc. (Nasdaq: CRDC ) today announced financial ... 2015. Cardica,s management will hold a conference call at ... and provide an update on the company,s business. ... fiscal 2015, we reintroduced a modified MicroCutter XCHANGE® 30 ... controlled commercial release is focusing primarily on customers in ...
(Date:5/6/2015)... Corp. (NASDAQ and MTA: CTIC) today reported financial results ... "After reporting positive top-line results from ... the quarter, we have subsequently received positive feedback from ... the potential opportunity for pacritinib to meet a current ... myelofibrosis, specifically in the portion of patients that have ...
Breaking Medicine Technology:WeissLaw LLP Investigates the Synageva Biopharma Corp. Acquisition 2Cardica Announces Fiscal 2015 Third Quarter Financial Results 2Cardica Announces Fiscal 2015 Third Quarter Financial Results 3Cardica Announces Fiscal 2015 Third Quarter Financial Results 4Cardica Announces Fiscal 2015 Third Quarter Financial Results 5Cardica Announces Fiscal 2015 Third Quarter Financial Results 6CTI BioPharma Reports First Quarter 2015 Financial Results 2CTI BioPharma Reports First Quarter 2015 Financial Results 3CTI BioPharma Reports First Quarter 2015 Financial Results 4CTI BioPharma Reports First Quarter 2015 Financial Results 5CTI BioPharma Reports First Quarter 2015 Financial Results 6CTI BioPharma Reports First Quarter 2015 Financial Results 7CTI BioPharma Reports First Quarter 2015 Financial Results 8CTI BioPharma Reports First Quarter 2015 Financial Results 9
... Calif., Dec. 20, 2010 Leader Ventures, an investment ... equipment financing to Carmot Therapeutics Inc., an innovative drug ... drug-discovery platform invented by Carmot co-founders Stig K. Hansen ... used to identify promising drug candidates in a broad ...
... Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) ... of a rolling submission for a Biologics License Application ... for the use of metreleptin to treat diabetes and/or ... patients with rare forms of lipodystrophy. Consistent with the ...
Cached Medicine Technology:Leader Ventures Supports Innovative Drug Discovery Company Carmot 2Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy 2Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy 3Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy 4
... Integre Duo is the first ... and green wavelengths. This advanced,laser ... instantly,select either a red or ... maximizes,treatment options and ensures effective,patient ...
... Gathering, managing, and transmitting data ... you were hired for. Dawnings ResultNet/Plus ... running your lab, not your communications ... with transmitting result data from largescale ...
... a comprehensive hemodynamic monitoring and information ... Patient demographics, clinical hemodynamic data, ... information all flow seamlessly into one ... data entry. Both images ...
Exxcel Soft ePTFE vascular graft, designed for exceptional kink resistance and crush resistance, maintains a Soft touch for easier handling during peripheral vascular bypass procedures and vascular a...
Medicine Products: